Mechanism of action (MoA) study 3month oral dosing of Vilprisan or Ulipristal in patients with uterine fibroids scheduled for hysterectomy

  • Williams, Alistair (Principal Investigator)

Project Details

StatusFinished
Effective start/end date1/09/1731/08/19

Funding

  • UK industry, commerce and public corporations: £23,279.00